Healthy Japanease adults
Conditions
Interventions
Oral ingestion of the test food(HBF2017-01) twice a day(after lunch and after dinner) for 12 weeks
Oral ingestion of the placebo control food twice a day(after lunch and after dinner) for 12 weeks
Sponsors
Hayashibara CO., LTD.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1)Healthy Japanease adults 2)Employees at the Hayashibara CO.,LTD. 3)Subjects who signed the informed consent for participation in the study 4)Higher BMI, body fat, fasting blood glucose level
Exclusion criteria
Exclusion criteria: 1)Subjects with medical history of sever disorders 2)Pregnant or have possibility to become pregnant during the study or lactating women 3)Subjects who judged as unsuitable for this study by the principal investigator for any reasons 4)Subjects who are being treated with hyperglycemia
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.Blood glucose after a 2-h OGTT * Measuring: at 0 and 12 weeks after ingestion | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Body weight, BMI, Body fat, Truncal fat, Blood pressure, Abdominal circumference, Waist circumference * Measuring: at 0,8 and 12 weeks after ingestion 2. Blood glucose, Insulin, HbA1c, ALT, AST, gamma-GTP, TG, Total choresterol, HDLchoresterol, LDLchoresterol, PAI-1 * Measuring: at 0 and 12 weeks after ingestion | — |
Countries
Japan
Contacts
Public ContactChiyo Yoshizane
Hayashibara CO., LTD. R&D Division, Development Unit
Outcome results
None listed